Contact Us

    Rudy Li, PhD, CFA

    Rudy Li, PhD, CFA is on Chardan's equity research team focusing on CNS-related companies. He has over six years of experience in biotech equity research and healthcare investment banking. Prior to joining Chardan, Rudy was an equity research analyst at Leerink Partners, covering SMID cap biotech companies across multiple therapeutic areas with a specialization in neuroscience. Rudy earned a Ph.D. in Chemistry from Stony Brook University, and a B.S. in Chemistry from Jilin University.

  • Rudy Li, PhD, CFA

    Senior Research Analyst, CNS


    • Biotechnology & Pharmaceuticals Research Coverage

      Company NameTicker

      Bright Minds Biosciences Inc.

      DRUG

      Centessa Pharmaceuticals plc

      CNTA

      Immunic, Inc.

      IMUX

      Mind Medicine Inc.

      MNMD

      Praxis Precision Medicines, Inc.

      PRAX

      Prothena Corporation plc

      PRTA

      Reviva Pharmaceuticals Holdings, Inc..

      RVPH

      Stoke Therapeutics, Inc.

      STOK

      Xenon Pharmaceuticals Inc.

      XENE

      Alto Neuroscience, Inc.

      ANRO

    See All Research

    Thank You!

    We've received your information, and we're processing your request.

    Get In Touch.

    One Pennsylvania Plaza
    Suite 4800
    New York, NY 10119

    +1 646-465-9000

    info@chardan.com

    careers@chardan.com

    hr@chardan.com

    All fields required
    SUBMIT